Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

forbes.com - Ken Silverstein - How Big Pharma Is Turning Industrial Heat Into A Strategic Asset
How Big Pharma Is Turning Industrial Heat Into A Strategic Asset
Forbes

metallurgical plant smoke from chimneys industry drone photography Inside a pharmaceutical plant, heat is everywhere—and until recently, almost nobody was paying attention to it. Steam rising from boilers. High-temperature reactions turn raw…

yahoo.com - By Andrew Silver - China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
Yahoo!

SHANGHAI, May 26 (Reuters) - China's booming pharmaceutical industry is not being impacted by Beijing's ‌tightening scrutiny over deals involving sensitive technologies, ‌the CEO of JW Therapeutics said Tuesday. Global drugmakers are…

globenewswire.com - Zealand Pharma - Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
GlobeNewswire

Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ('Zealand Pharma' or the “Company”) (Nasdaq: ZEAL) (CVR-no.

globenewswire.com - Zealand Pharma - Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
GlobeNewswire

Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…

fool.com - Prosper Junior Bakiny - President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?
The Motley Fool

President Trump has made it a priority to address the U.S.'s high drug prices. His administration's Most-Favored-Nation (MFN) policy, centered on the idea that Americans shouldn't have to pay more for medicines than other developed nations, seeks…

statnews.com - Tahir Amin - The innovation trap: How pharma weaponizes a word to extend monopolies
The innovation trap: How pharma weaponizes a word to extend monopolies
STAT

Sen. John Cornyn: How many patents do you [have?] AbbVie CEO Richard Gonzalez: … A hundred and thirty-six patents. Cornyn: A hundred and thirty-six patents on one drug? Gonzalez: But, well, remember, Humira is like nine different drugs, or…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Cut to Market Perform at Raymond James Financial
BridgeBio Pharma (NASDAQ:BBIO) Cut to Market Perform at Raymond James Financial
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) was downgraded by stock analysts at Raymond James Financial from an 'outperform' rating to a 'market perform' rating in a research report issued on Tuesday. BridgeBio's Volatile Week Puts Biotech…

marketbeat.com - HighTower Advisors LLC Grows Holdings in Royalty Pharma PLC $RPRX
HighTower Advisors LLC Grows Holdings in Royalty Pharma PLC $RPRX
MarketBeat

HighTower Advisors LLC grew its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 27.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 281,122…

bloomberg.com - Eru Ishikawa - Astellas Says Newer Drugs Set to Drive Profit Growth by 2030
Astellas Says Newer Drugs Set to Drive Profit Growth by 2030
Bloomberg

Astellas Pharma Inc. will lean on high-margin brands like cancer drug Padcev and eye treatment Izervay to reach a five-year target of at least ¥4.3 trillion ($27 billion) in cumulative core operating profit before R&D expenses. The company's…

globenewswire.com - Nxera Pharma - Nxera's President & CEO to Participate in a 'Fireside Chat' at the Jefferies New York Healthcare Conference 2026
Nxera's President & CEO to Participate in a 'Fireside Chat' at the Jefferies New York Healthcare Conference 2026
GlobeNewswire

Tokyo, Japan and Cambridge, UK, 26 May 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces its President & CEO, Chris Cargill, will participate in a ‘Fireside Chat' at the Jefferies…

thehindubusinessline.com - Buzzing stocks: BEL, Paytm, JSW Energy, NLC India, Fredun Pharma, Raymond, Pasupathi Acrylon, Innovision, Bhageria Ind
Buzzing stocks: BEL, Paytm, JSW Energy, NLC India, Fredun Pharma, Raymond, Pasupathi Acrylon, Innovision, Bhageria Ind
BusinessLine

Bharat Electronics Ltd has secured additional orders worth Rs 608 crore since the last disclosure on 5th May 2026. Major orders received include communication equipment, avionics, information fusion centre, coastal surveillance radar system…

digg.com - Nathan Benaich - Perceptic Raises $12M Seed Round To Automate Drug Discovery With AI · Digg
Perceptic Raises $12M Seed Round To Automate Drug Discovery With AI · Digg
Basic Intelligence

Original post i'm excited to unveil a $12m round for @perceptictech, operationalizing frontier ai systems to transform biopharma from @airstreet @accel elder gull and angels from ai labs @ashedwardst of fern labs (now @poolsideai) intro'd me to…

rediff.com - Rediff News - Stock markets turn flat amid rise in crude oil prices
Stock markets turn flat amid rise in crude oil prices
Rediff.com

Market benchmark indices Sensex and Nifty were trading flat after falling in early trade on Tuesday amid mixed trend in Asian equities and a rise in crude oil prices. The 30-share BSE Sensex declined 264.82 points to 76,224.14 in opening trade. The…

thehindubusinessline.com - KS Badri Narayanan - Q4 Results 26th May Highlights: EID Parry posts Q4 loss, Marksans Pharma & Astra Microwave profit up, AIA Engineering profit down, ONGC, Brainbees, JK Tyre, GIC, IRCTC, Gujarat Gas, Sumitomo Chemical to announce Q4 results
Q4 Results 26th May Highlights: EID Parry posts Q4 loss, Marksans Pharma & Astra Microwave profit up, AIA Engineering profit down, ONGC, Brainbees, JK Tyre, GIC, IRCTC, Gujarat Gas, Sumitomo Chemical to announce Q4 results
BusinessLine

Q4 Results Today, 26th May 2026 Highlights: Find all the latest Q4 results 2026 updates of 7NR Retail, Aartech Solonics, Abhijit Trading Company, Apex Capital And Finance, Adinath Textiles, Adishakti Loha and Ispat, Aeonx Digital Technology, Aequs…

rediff.com - Nandita Malik - Stock markets turn flat after falling in early trade
Stock markets turn flat after falling in early trade
Rediff.com

The BSE benchmark traded 44.43 points up at 76,521.93, and the Nifty quoted 17.20 points higher at 24,048.85. The BSE benchmark traded 44.43 points up at 76,521.93, and the Nifty quoted 17.20 points higher at 24,048.85. Brent crude, the global oil…

Receive a Daily briefing on Pharma Industry News

Get Started